sulpiride has been researched along with Cognition Disorders in 16 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 9.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 5.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| "A shorter duration of untreated psychosis has been associated with better prognosis in schizophrenia." | 1.39 | Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. ( Higuchi, Y; Kawasaki, Y; Miyanishi, T; Seo, T; Sumiyoshi, T; Suzuki, M, 2013) |
| " The alleviation of the deficit with chronic administration of a DA precursor points to a possible line of treatment for the cognitive effects of developmental lead exposure." | 1.27 | Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys. ( Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Axelsson, SFA | 1 |
| Horst, NK | 1 |
| Horiguchi, N | 1 |
| Roberts, AC | 1 |
| Robbins, TW | 2 |
| Bak, N | 1 |
| Ebdrup, BH | 1 |
| Oranje, B | 1 |
| Fagerlund, B | 1 |
| Jensen, MH | 1 |
| Düring, SW | 1 |
| Nielsen, MØ | 1 |
| Glenthøj, BY | 1 |
| Hansen, LK | 1 |
| Nikiforuk, A | 1 |
| Popik, P | 1 |
| Crespo-Facorro, B | 1 |
| Rodríguez-Sánchez, JM | 1 |
| Pérez-Iglesias, R | 1 |
| Mata, I | 1 |
| Ayesa, R | 1 |
| Ramirez-Bonilla, M | 1 |
| Martínez-Garcia, O | 1 |
| Vázquez-Barquero, JL | 1 |
| Goldberg, TE | 1 |
| Gomar, JJ | 1 |
| Ahn, YM | 2 |
| Lee, KY | 1 |
| Kim, CE | 1 |
| Kim, JJ | 1 |
| Kang, DY | 1 |
| Jun, TY | 1 |
| Choi, JS | 1 |
| Chung, IW | 1 |
| Kim, SH | 2 |
| Hwang, SS | 2 |
| Kim, YS | 2 |
| Jung, DC | 1 |
| Koychev, I | 1 |
| McMullen, K | 1 |
| Lees, J | 1 |
| Dadhiwala, R | 1 |
| Grayson, L | 1 |
| Perry, C | 1 |
| Schmechtig, A | 1 |
| Walters, J | 1 |
| Craig, KJ | 1 |
| Dawson, GR | 1 |
| Dourish, CT | 1 |
| Ettinger, U | 1 |
| Wilkinson, L | 1 |
| Williams, S | 1 |
| Deakin, JF | 1 |
| Barkus, E | 1 |
| Galderisi, S | 1 |
| Mucci, A | 1 |
| Bitter, I | 1 |
| Libiger, J | 1 |
| Bucci, P | 1 |
| Fleischhacker, WW | 1 |
| Kahn, RS | 1 |
| Higuchi, Y | 1 |
| Sumiyoshi, T | 1 |
| Seo, T | 1 |
| Miyanishi, T | 1 |
| Kawasaki, Y | 1 |
| Suzuki, M | 1 |
| Limosin, F | 1 |
| Mortimer, AM | 1 |
| Joyce, E | 1 |
| Balasubramaniam, K | 1 |
| Choudhary, PC | 1 |
| Saleem, PT | 1 |
| Mehta, MA | 1 |
| Sahakian, BJ | 1 |
| McKenna, PJ | 1 |
| Darcourt, G | 1 |
| Pelc, I | 1 |
| Levin, ED | 1 |
| Bowman, RE | 1 |
| Wegert, S | 1 |
| Vuchetich, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia[NCT03775564] | 60 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sulpiride and Cognition Disorders
| Article | Year |
|---|---|
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; | 2006 |
7 trials available for sulpiride and Cognition Disorders
| Article | Year |
|---|---|
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
Topics: Adult; Algorithms; Amisulpride; Antipsychotic Agents; Cognition Disorders; Electroencephalography; E | 2017 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Fe | 2009 |
Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cognition Disorders; Female; Follow-Up Studies; Humans; Ma | 2009 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Fema | 2012 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzot | 2013 |
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose- | 2007 |
Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
Topics: Adult; Affect; Antipsychotic Agents; Association Learning; Attention; Cognition Disorders; Cross-Ove | 1999 |
8 other studies available for sulpiride and Cognition Disorders
| Article | Year |
|---|---|
Flexible versus Fixed Spatial Self-Ordered Response Sequencing: Effects of Inactivation and Neurochemical Modulation of Ventrolateral Prefrontal Cortex.
Topics: Animals; Antipsychotic Agents; Baclofen; Callithrix; Cognition Disorders; Dopamine; Dopamine D2 Rece | 2021 |
Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Attention; Cognition Disorders; Disease Models, Animal; | 2013 |
Targeting cognition in schizophrenia research: from etiology to treatment.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepin | 2009 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive | 2010 |
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Electroencephalography; | 2013 |
Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
Topics: Amisulpride; Antipsychotic Agents; Cognition Disorders; Humans; Schizophrenia; Sulpiride | 2000 |
[Sulpiride and psychic decompensation].
Topics: Anxiety; Autistic Disorder; Cognition Disorders; Depression; Humans; Psychotic Disorders; Sulpiride | 1976 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; L | 1987 |